CARLO STELLA, CARMELO

CARLO STELLA, CARMELO  

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale  

Mostra records
Risultati 1 - 20 di 125 (tempo di esecuzione: 0.008 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 1-gen-2009 A. GiacominiC. LavazzaD. SiaC. Carlo-StellaA. Gianni + Article (author) -
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®) 1-gen-2009 A. GuidettiC. Carlo-StellaA.M. Gianni + Article (author) -
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH) 1-gen-2004 C. Carlo-StellaA. GuidettiA.M. Gianni + Article (author) -
Amifostine (WR-2721) selective protection against melphalan genotoxicity 1-gen-2000 C. Carlo-Stella + Article (author) -
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells 1-gen-2008 C. Carlo StellaC. LavazzaA.M. Gianni + Book Part (author) -
Antitumor activity of adenovirally transduced CD34+ cells expressing membrane-bound TRAIL 1-gen-2007 C. Carlo StellaC. LavazzaA. M. Gianni + Book Part (author) -
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (mTRAIL) 1-gen-2006 C. Carlo-StellaC. LavazzaA.M. Gianni + Article (author) -
Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders 1-feb-2014 S.L. LocatelliC. Carlo-Stella + Article (author) -
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY 1-gen-2015 V. ZanonC. Carlo-StellaS. Della BellaD. Mavilio + Article (author) -
Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi 1-lug-2014 C. Carlo-StellaP. Corradini + Article (author) -
Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma : Final results of a multicenter phase II study 1-gen-2016 C. Carlo Stella + Article (author) -
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts 1-set-2014 S.L. LocatelliC. Carlo-Stella + Article (author) -
Biology and clinical applications of marrow mesenchymal stem cells 1-gen-2005 C. Carlo-StellaA.M. Gianni Article (author) -
Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells 1-gen-2002 C. Carlo Stella + Article (author) -
Bone Marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide 1-gen-2014 C. Carlo-Stella + Article (author) -
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cell vaccination: a phase I trial in metastatic melanoma 15-ago-2004 C. Carlo-StellaA. GuidettiA. Gianni + Article (author) -
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation : results from a named patient program at four Italian centers 1-mar-2015 C. Carlo-StellaP. Corradini + Article (author) -
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice 1-gen-2006 C. Carlo-StellaA. GuidettiC. LavazzaL. FarinaA.M. GianniP. Corradini + Article (author) -
Cellule staminali emopoietiche 1-gen-2007 C. Carlo Stella Book Part (author) -
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 15-feb-2018 Manzoni, MartinaLOCATELLI, SILVIA LAURAANNUNZIATA, SALVATORENeri, AntoninoCarlo-Stella, Carmelo + Article (author) -